Redhill Biopharma
RDHL
S$1.91
Share price
-9.20%
Change (1 day)
-85.55%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Net assets
Net assets on the balance sheet as of December 2024 : -S$6.03 Million
According to Redhill Biopharma's latest financial reports the company has -S$6.03 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Redhill Biopharma - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $S$2.73 M | -104.21% |
| 2022-12-31 | $-S$64.89 Million | -640.79% |
| 2021-12-31 | $S$11.99 M | -34.58% |
| 2020-12-31 | $S$18.34 M | -77.33% |
| 2019-12-31 | $S$80.89 M | 15.68% |
| 2018-12-31 | $S$69.92 M | 16.02% |
| 2017-12-31 | $S$60.27 M | -33.58% |
| 2016-12-31 | $S$90.74 M | 6.79% |
| 2015-12-31 | $S$84.98 M | 157.14% |
| 2014-12-31 | $S$33.04 M | 118.73% |
| 2013-12-31 | $S$15.1 M | -35.04% |
| 2012-12-31 | $S$23.25 M | -4.41% |
| 2011-12-31 | $S$24.33 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | S$103.66 B | -1,719,339.80% | 🇫🇷 France |
 Merck MRK | S$62.31 B | -1,033,625.52% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$22.71 B | -376,828.59% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | S$2.29 B | -38,090.39% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | S$8.07 B | -133,967.18% | 🇮🇱 Israel |